← Leaderboards
William J Steinbach
Duke University
$15,812,111
Attributed
$34,934,383
Total exposure
21
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.7M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$36,861,961 · 22
By mechanism
R01$27,060,051 · 8
R21$2,165,521 · 5
U54$2,066,502 · 2
R44$1,475,794 · 1
T32$1,129,671 · 1
P01$1,097,792 · 1
Top collaborators
- Brian T Fisher22 shared
- Praveen Rao Juvvadi10 shared
- Joseph Heitman8 shared
- Janet A Englund6 shared
- Betsy C. Herold6 shared
- David R Andes5 shared
- Martin D Burke5 shared
- Timothy M Fan5 shared
Most similar at Duke University
Same institution · by research overlap
- Joseph Heitman$44,576,851
- John R. Perfect$12,760,645
- Paul B Rosenberg$6,076,972
- Maria Schumacher$11,809,128
- Praveen Rao Juvvadi$1,385,315
Others in their field
Top investigators on “Mycoses”
- Clarence Buddy Creech · Vanderbilt University Medical Center$43,087,946
- Bruce Steven Klein · University Of Wisconsin-Madison$20,250,427
- Maurizio Del Poeta · Northport Va Medical Center$16,685,339
- Hiten D Madhani · University Of California, San Francisco$15,370,430
- Robert Andrew Cramer · Sloan-Kettering Inst Can Research$14,301,441
- David S Perlin · Hackensack University Medical Center$12,724,411
Research focus
MycosesInfectionSiteAspergillosisCandidiasisAntifungal AgentsMortalityGuidelinesProspectiveFutureMorbidity - Disease RateChildhoodPathogenChildImmunocompromised HostResponseBaseCommunicable DiseasesResearch PersonnelCause Of DeathFoundationsDesignAntifungal TherapyPharmaceutical Preparations
Grant awards (73)
Pediatric Fungal Network STudy of Rare Invasive Fungal DisEases in Immunocompromised Pediatric Patients (PFN-STRIDE)$1,927,578
U54 · FY2025 · AI
Multi-center Evaluation of the Threat of Established and Emerging Respiratory Viral Infections in Pediatric Transplant Recipients$1,502,393
R01 · FY2025 · AI · contact PI
Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial$1,223,727
R01 · FY2025 · AI · contact PI
Calcineurin Control over Aspergillus Fumigatus Antifungal Response Mechanisms$503,706
R01 · FY2025 · AI
PKA-Dependent Autophagy Control in Aspergillus fumigatus Pathogenesis$212,099
R21 · FY2025 · AI · contact PI
Pediatric Fungal Network's (PFN) STudy of Rare Invasive Fungal DisEases in Immunocompromised Pediatric Patients (STRIDE) Career Enhancement Core$138,924
U54 · FY2025 · AI · contact PI
Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial$28,350
R01 · FY2025 · AI · contact PI
Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial$28,350
R01 · FY2025 · AI · contact PI
Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial$28,350
R01 · FY2025 · AI · contact PI
Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial$28,350
R01 · FY2025 · AI · contact PI
Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial$28,350
R01 · FY2025 · AI · contact PI
Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial$28,350
R01 · FY2025 · AI · contact PI
Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial$1,383,097
R01 · FY2024 · AI · contact PI
Calcineurin Control over Aspergillus Fumigatus Antifungal Response Mechanisms$521,377
R01 · FY2024 · AI
PKA-Dependent Autophagy Control in Aspergillus fumigatus Pathogenesis$251,107
R21 · FY2024 · AI · contact PI
Multi-center Evaluation of the Threat of Established and Emerging Respiratory Viral Infections in Pediatric Transplant Recipients$1
R01 · FY2024 · AI · contact PI
Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial$1,394,565
R01 · FY2023 · AI · contact PI
Multi-center Evaluation of the Threat of Established and Emerging Respiratory Viral Infections in Pediatric Transplant Recipients$842,739
R01 · FY2023 · AI · contact PI
Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial$1,468,578
R01 · FY2022 · AI · contact PI
Multi-center Evaluation of the Threat of Established and Emerging Respiratory Viral Infections in Pediatric Transplant Recipients$845,245
R01 · FY2022 · AI · contact PI
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections$703,340
R01 · FY2022 · AI · contact PI
Development of non-toxic amphotericin B derivatives targeting invasive fungal infections$702,349
R01 · FY2022 · AI
Calcineurin regulatory network control of Aspergillus fumigatus hyphal septation$163,465
R21 · FY2022 · AI · contact PI
Development of non-toxic amphotericin B derivatives targeting invasive fungal infections$714,404
R01 · FY2021 · AI
Multi-center Evaluation of the Threat of Established and Emerging Respiratory Viral Infections in Pediatric Transplant Recipients$675,979
R01 · FY2021 · AI · contact PI
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections$472,708
R01 · FY2021 · AI · contact PI
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections$305,715
R01 · FY2021 · AI · contact PI
Multi-center evaluation of the threat of established and emerging respiratory viral infections in pediatric transplant recipients$262,298
R01 · FY2021 · AI · contact PI
Calcineurin regulatory network control of Aspergillus fumigatus hyphal septation$241,500
R21 · FY2021 · AI · contact PI
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections$787,070
R01 · FY2020 · AI · contact PI
Development of non-toxic amphotericin B derivatives targeting invasive fungal infections$745,652
R01 · FY2020 · AI
Structural Biological Development of Fungal-Specific Calcineurin Inhibitors$669,233
R56 · FY2020 · AI
Molecular Mycology and Pathogenesis Training Program$343,402
T32 · FY2020 · AI
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections$798,798
R01 · FY2019 · AI · contact PI
Development of non-toxic amphotericin B derivatives targeting invasive fungal infections$757,553
R01 · FY2019 · AI
Molecular Mycology and Pathogenesis Training Program$415,344
T32 · FY2019 · AI
Phosphoproteomic identification of Aspergillus fumigatus virulence-associated protein kinase A downstream effectors$240,750
R21 · FY2019 · AI · contact PI
Inhibitor Testing Core$204,876
P01 · FY2019 · AI · contact PI
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections$820,854
R01 · FY2018 · AI · contact PI
Development of non-toxic amphotericin B derivatives targeting invasive fungal infections$801,630
R01 · FY2018 · AI
Developing a novel antifungal targeting Gwt1 for the treatment of invasive aspergillosis and rare mold infections$725,501
R44 · FY2018 · AI
Fungal biomarkers for diagnosis and response to therapy for pediatric candidemia$631,470
R01 · FY2018 · HD · contact PI
Molecular Mycology and Pathogenesis Training Program$370,925
T32 · FY2018 · AI
Inhibitor Testing Core$212,098
P01 · FY2018 · AI · contact PI
Phosphoproteomic identification of Aspergillus fumigatus virulence-associated protein kinase A downstream effectors$199,375
R21 · FY2018 · AI · contact PI
Defining the Aspergillus fumigatus Calcineurin-Dependent Regulatory Network through Whole Phosphoproteome Analysis$198,750
R21 · FY2018 · AI · contact PI
Developing a novel antifungal targeting Gwt1 for the treatment of invasive aspergillosis and rare mold infections$750,293
R44 · FY2017 · AI
Fungal biomarkers for diagnosis and response to therapy for pediatric candidemia$640,677
R01 · FY2017 · HD · contact PI
Structural Biological Development of Fungal-Specific Calcineurin Inhibitors$593,377
R01 · FY2017 · AI
Multi-center studies to improve diagnosis and treatment of pediatric candidiasis$542,532
R01 · FY2017 · AI
Defining the Aspergillus fumigatus Calcineurin-Dependent Regulatory Network through Whole Phosphoproteome Analysis$238,500
R21 · FY2017 · AI · contact PI
Inhibitor Testing Core$235,320
P01 · FY2017 · AI · contact PI
Fungal biomarkers for diagnosis and response to therapy for pediatric candidemia$642,589
R01 · FY2016 · HD · contact PI
Multi-center studies to improve diagnosis and treatment of pediatric candidiasis$613,182
R01 · FY2016 · AI
Structural Biological Development of Fungal-Specific Calcineurin Inhibitors$609,599
R01 · FY2016 · AI
Inhibitor Testing Core$219,062
P01 · FY2016 · AI · contact PI
Fungal biomarkers for diagnosis and response to therapy for pediatric candidemia$642,649
R01 · FY2015 · HD · contact PI
Structural Biological Development of Fungal-Specific Calcineurin Inhibitors$618,104
R01 · FY2015 · AI
Multi-center studies to improve diagnosis and treatment of pediatric candidiasis$597,256
R01 · FY2015 · AI
Inhibitor Testing Core$226,436
P01 · FY2015 · AI · contact PI
Non-Immunosuppressive Cyclosporine Analogs for Novel Antifungal Therapies$223,992
R43 · FY2015 · AI
Fungal biomarkers for diagnosis and response to therapy for pediatric candidemia$691,645
R01 · FY2014 · HD · contact PI
Structural Biological Development of Fungal-Specific Calcineurin Inhibitors$637,517
R01 · FY2014 · AI
Multi-center studies to improve diagnosis and treatment of pediatric candidiasis$597,256
R01 · FY2014 · AI
Multi-center studies to improve diagnosis and treatment of pediatric candidiasis$598,320
R01 · FY2013 · AI
Identification of calcineurin-binding proteins in A. fumigatus septum formation$184,475
R21 · FY2013 · AI · contact PI
Identification of calcineurin-binding proteins in A. fumigatus septum formation$235,500
R21 · FY2012 · AI · contact PI
Calcineurin Inhibition to Halt Aspergillus fumigatus Hyphae and Virulence$392,500
R56 · FY2010 · AI · contact PI
Calcineurin and Aspergillus fumigatus Pathogenesis$120,501
K08 · FY2008 · AI · contact PI
Calcineurin and Aspergillus fumigatus Pathogenesis$120,501
K08 · FY2007 · AI · contact PI
Calcineurin and Aspergillus fumigatus Pathogenesis$120,501
K08 · FY2006 · AI · contact PI
Calcineurin and Aspergillus fumigatus Pathogenesis$109,701
K08 · FY2005 · AI
Calcineurin and Aspergillus fumigatus Pathogenesis$109,701
K08 · FY2004 · AI